Belgrade, Mont.-based Xtant Medical's second quarter revenue reached $21.46 million, according to Founders Daily.
Here are three quick points:
1. Analysts expected second quarter revenue of $21.59 million.
2. Most recently, CEO Daniel S. Goldberger bought 5,000 company shares, at $2.34 per share, on May 10, 2016.
3. Director Kent L. Swanson purchased 3,300 shares, at $2.83 per share, on Dec. 3, 2015.